Severe autoimmune diseases (ADs) are a major source of disability and reduced quality of life and may result in shortened life expectancy, particularly in treatment-resistant patients. For several decades, allogeneic and autologous haematopoietic stem cell transplantation (HSCT) has been the focus of scientific investigation as a potential means of delivering 'one-off' intensive treatment in severe ADs. Improvements in the clinical safety of HCST were followed by its increasing use in recent ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Clinical stem cell therapies for severe autoimmune diseases.
If you are the owner of this record, you can report an update to it here: Report update to this record